...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Now that we're a small cap stock....

This is for oncology but there are similar kninds of "rules of thumb" for other non-revenue biotechs coming into phase 3 results.

Over 300 million market cap is good!

https://www.thestreet.com/story/12696926/1/the-feuerstein-ratain-rule-update-still-perfect-predicting-small-cap-cancer-drug-failure.html

 

 

Share
New Message
Please login to post a reply